Search results
FDA approves first self-test collection kit for HPV
Medical Xpress· 1 day agoMore than half of U.S. women diagnosed with cervical cancer have never been screened or screened only infrequently for the virus, the kit's maker Roche...
FDA approves self-collection screening tests for HPV, allowing women to avoid pelvic exams for...
FierceBiotech· 2 days agoThe FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves...
FDA Approves New Drug for Deadly Lung Cancer
Clayton News Daily· 2 hours agoThe U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly,...
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE...
FOX 5 San Diego· 16 hours agoAmgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult ...
How Long Can I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 3 hours agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
FDA Approves Tarlatamab for Extensive-Stage SCLC
Medscape· 1 day agoContinued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 9 hours agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
FDA greenlights self-collection of vaginal samples for cervical cancer screening
KMBC-TV Kansas City· 20 hours agoTwo health care businesses – biotechnology company Roche and medical technology firm Becton, Dickson...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 18 hours agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
Amgen’s IMDELLTRA receives FDA approval for lung cancer treatment
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThis DLL3-targeting therapy in ES-SCLC comprises a transformative option demonstrating long-lasting...